- Home
- AVTX vs MDRR Comparison
AVTX vs MDRR Comparison
Compare AVTX & MDRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVTX
- MDRR
- Stock Information
- Founded
- AVTX 2011
- MDRR 2015
- Country
- AVTX United States
- MDRR United States
- Employees
- AVTX N/A
- MDRR N/A
- Industry
- AVTX Biotechnology: Pharmaceutical Preparations
- MDRR Real Estate Investment Trusts
- Sector
- AVTX Health Care
- MDRR Real Estate
- Exchange
- AVTX Nasdaq
- MDRR Nasdaq
- Market Cap
- AVTX 13.5M
- MDRR 13.4M
- IPO Year
- AVTX 2015
- MDRR 2018
- Fundamental
- Price
- AVTX $7.56
- MDRR $12.73
- Analyst Decision
- AVTX Buy
- MDRR
- Analyst Count
- AVTX 1
- MDRR 0
- Target Price
- AVTX $35.00
- MDRR N/A
- AVG Volume (30 Days)
- AVTX 29.9K
- MDRR 6.5K
- Earning Date
- AVTX 08-12-2024
- MDRR 08-09-2024
- Dividend Yield
- AVTX N/A
- MDRR 1.57%
- EPS Growth
- AVTX N/A
- MDRR N/A
- EPS
- AVTX N/A
- MDRR N/A
- Revenue
- AVTX $807,000.00
- MDRR $10,168,744.00
- Revenue This Year
- AVTX N/A
- MDRR N/A
- Revenue Next Year
- AVTX N/A
- MDRR N/A
- P/E Ratio
- AVTX N/A
- MDRR N/A
- Revenue Growth
- AVTX N/A
- MDRR N/A
- 52 Week Low
- AVTX $3.95
- MDRR $8.24
- 52 Week High
- AVTX $71.04
- MDRR $14.95
- Technical
- Relative Strength Index (RSI)
- AVTX 37.94
- MDRR 56.39
- Support Level
- AVTX $6.84
- MDRR $12.20
- Resistance Level
- AVTX $8.22
- MDRR $12.95
- Average True Range (ATR)
- AVTX 1.33
- MDRR 0.33
- MACD
- AVTX -0.12
- MDRR 0.02
- Stochastic Oscillator
- AVTX 14.31
- MDRR 76.84
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
About MDRR Medalist Diversified REIT Inc.
Medalist Diversified REIT Inc is engaged in the acquisition, reposition, renovation, leasing, and managing of income-producing properties with a focus on commercial properties, including flex-industrial and retail properties, multi-family residential properties, and hotel properties. The company operates as a UPREIT and owns properties through its subsidiary, Medalist Diversified Holdings, LP. Its principal objectives include sourcing value-added Investments in markets in which it maintains deep industry relationships and local market knowledge and the creation of value for stockholders by utilizing its relationships and local knowledge of commercial real estate investment, management, and disposition.